Nestle, GE to collaborate on body composition, health research
LAUSANNE, Switzerland The Nestle Research Center here and GE Global Research on Wednesday announced a collaboration to scientifically assess associations between body composition, metabolic status, diet and lifestyle habits. A primary goal of the collaboration is to gain a deeper understanding of the connection between body composition, metabolic profile and health.
GE Healthcare’s Lunar iDXA system, an imaging technology, will be used by Nestle scientists to measure subjects’ body fat, muscle and bone mineral density, extending beyond the measures of body mass index and waist-hip-ratio. Researchers will study the correlations between lifestyle habits, body composition measurements and metabolic data to better understand the biological drivers of individuals’ metabolism and health.
“Through this collaboration with GE we have the opportunity to use cutting-edge diagnostic tools to increase our understanding of how nutrition and lifestyle choices impact body composition and metabolic health,” stated Peter van Bladeren, head of Nestle Science and Research. “With this knowledge, Nestle can continue to deliver science-based nutritional products to improve and enhance the quality of peoples’ lives.”
The results will provide direction for the development of non-invasive, rapid, precise and accurate assessment tools for clinicians to evaluate the impact of nutritional interventions on metabolic status and overall health. Additionally, this data will help researchers identify specific metabolic parameters that can potentially be improved via diet and lifestyle.
“In the face of a worldwide obesity epidemic, providing better tools to track the functional benefits of weight management, nutrition and lifestyle has become an international healthcare priority,” added Mark Little, senior vice president and director, GE Global Research. “The use of GE’s diagnostic tools will provide Nestle scientists with more information on how diet and lifestyle measures can be optimized to help people lead healthier lives and ultimately make healthcare systems more efficient by more effectively managing and treating obesity.”
Boiron’s Arnicare Gel available as homeopathic pain reliever
NEWTOWN SQUARE, Pa. Boiron is pitching its homeopathic pain reliever Arnicare Gel to Americans on the go, the company announced last week.
“Individuals unaccustomed to tasks such as gardening or home improvement and fitness buffs and athletes who want to maintain their active lifestyles will find that Arnicare Gel is one of the safest options for self-treatment,” stated Christophe, Merville, Boiron’s pharmaceutical development manager. “Applying a thin layer of the gel on the affected area soon after an injury occurs can provide adequate relief of muscle aches, stiffness and bruising. Persons of all ages can recover more quickly no matter what the activity.”
The active ingredient in Arnicare Gel is Arnica montana, the company stated, also known as the Mountain daisy, a perennial plant commonly found in the Northwestern parts of the U.S. and Central Europe.
Arnicare Gel is available in a small 2.6 oz. tube.
Oragenics announces test marketing of Probiora3 probiotic
ALACHUA, Fla. Oragenics last week announced the test marketing of its oral probiotic product, Probiora3. The chewable tablets help to whiten teeth and improve breath though the use of a unique combination of safe, naturally occurring bacteria that are released in the mouth by chewing on a mint-flavored tablet twice daily.
“I am enthusiastic about the current and potential consumer benefits of Probiora3, and recognize that it marks the first of what we hope are a long line of pharma and non-pharma products to reach market in time to come,” stated Rick Welch, Oragenics chairman.
The company expects to begin direct-to-consumer sales within the next month through a subsidiary company and to bring the product to the public’s attention through the media.